中南大学 huanghe

Language : English

黄河

Home

Journal Publications

Research Projects

Books

Patents

Teaching

Honors and Awards

Recommended Ph.D.Supervisor
Recommended MA Supervisor

MOBILE Version

Journal Publications

Current position: Home > Journal Publications

[1]Xiaorui Zhang, Yunzhe Zhou, Chunmei Fan, Xueying Huang, Linna Long, Siying Yu, Honghong Wang#, He Huang#. Visualization and bibliometric analysis of occupational exposure among nurses in Asia. Heliyon, 2023,9(11): e21289. (SCI, JCR1, IF: 4), 2023, 9 (11) : e21289.
[2]Nianfeng Zhang #, Linna Long #, Guang Li, Xingang Wu, Shubin Peng, Yu Jiang, Anping Xiang, Xianhua Mao, He Huang*, Zhiying Yang*. Preliminary study on the mechanism of POFUT1 in colorectal cancer. Med Oncol, 2023;40(8):235. (SCI, JCR3, IF: 3.4), 2023
[3]Yian Wang, Qijia Yan, Chunmei Fan, Yongzhen Mo, Yumin Wang, Xiayu Li, Qianjin Liao, Can Guo, Guiyuan Li, Zhaoyang Zeng, Wei Xiong*, He Huang*. Overview and Countermeasures of Cancer burden in China. SCIENCE CHINA Life Sciences, 2023 Apr 13. (JCR1, IF: 10.372)
[4]Linna Long, Xueying Huang, Siying Yu, Jiahui Fan, Xia Li, Rong Xu, Xiaorui Zhang, He Huang*. The research status and prospects of MUC1 in immunology. Hum Vaccin Immunother, 2023;2172278 (SCI, JCR2, IF: 4.526)
[5]Rong Xu#, Xin Wu#, Ashuai Du, Qiangqiang Zhao*, He Huang*. Identification of cuproptosis-related long non-coding ribonucleic acid signature as a novel prognosis model for colon cancer. Am J Cancer Res, 2022,12(11):5241-5254. (SCI, JCR2, IF: 5.942)
[6]Rong Xu, Zhiying Yang, Jiahui Fan, Xueying Huang, Linna Long, Siying Yu, Xia Li, Xiaorui Zhang, He Huang*. Knowledge basic and emerging trends in YAP1 research. Am J Transl Res, 14(9):6467-6483. (SCI, JCR2, IF:4.060)
[7]Chunmei Fan, Fang Xiong, Yanyan Tang, Panchun Li, Kunjie Zhu, Yongzhen Mo, Yumin Wang, Shanshan Zhang, Zhaojiang Gong, Qianjin Liao, Guiyuan Li, Zhaoyang Zeng, Can Guo, Wei Xiong*, He Huang*. Construction of a lncRNA–mRNA Co-Expression Network for Nasopharyngeal Carcinoma. Front Oncol, 2022, 12:809760. (SCI, JCR1, IF:5.738)
[8]Xia Li, Yurong Wang, Chunju Xu, Xirenguli Reheman, Yuxi Wang, Rong Xu, Jiahui Fan, Xueying Huang, Linna Long, Siying Yu, He Huang*. Epigenetic mechanism and survival prognosis analysis of serum exosomes from ovarian cancer patients based on sequencing technology and Bioinformatics. Front Genet, 2022, 12: 850089. (SCI, JCR2, IF: 4.599)
[9]Pan Wu, Yuhang Liu, Ruijia Zhou, Lingyun Liu, Hongli Zeng, Fang Xiong, Shanshan Zhang, Zhaojian Gong, Wenling Zhang, Can Guo, Fuyan Wang, Ming Zhou, Xuyu Zu, Zhaoyang Zeng, Yong Li, Guiyuan Li, He Huang,* Wei Xiong*. Extrachromosomal Circular DNA: A New Target in Cancer. Front Oncol, 2022, 12:814504. (SCI, JCR1, IF: 6.244) Review
[10]Xueying Huang, Zhiying Yang, Jinning Zhang, Ruojiao Wang, Jiahui Fan, Heng Zhang, Rong Xu, Xia Li, Siying Yu, Linna Long, He Huang*. A bibliometric analysis based on Web of Science: Current perspectives and potential trends of SMAD7 in oncology. Front Cell Dev Biol , 2022, 9: 712732. (SCI, JCR2, IF: 6.684), 2022
[11]Youxiang Hou , Zhanfei Dong, Wei Zhong, Linglong Yin, Xiong Li, Gulina Kuerban*, He Huang*. FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription. Biomed Res Int, 2022:3032590. (SCI, JCR3, IF: 3.411)
[12]Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomed Pharmacother, 2020, 131, 110768. (SCI, JCR2, IF: 6.529)
[13]Qingxin Zhou#, Meihua Lin#, Xing Feng#, Fei Ma#, Yuekun Zhu, Xing Liu, Chao Qu, Hong Sui, Bei Sun, Anlong Zhu, Heng Zhang, He Huang, Zhi Gao, Yongxiang Zhao, Jiangyun Sun, Yuxian Bai, Junfei Jin*, Xuehui Hong*, Chang Zou*, Zhiyong Zhang*. Targeting CLK3 Inhibits the Progression of Cholangiocarcinoma by Reprogramming Nucleotide Metabolism. J Exp Med, 2020, 217(8):e20191779. (SCI, JCR1, Nature Index, IF: 10.892)
[14]Heng Zhang, He Huang*, Xing Feng, Huiwen Song, Zhiyong Zhang*, Aizong Shen*, Xingfeng Qiu*. Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells. Theranostics, 2020, 10(3):1046-1059. (SCI, JCR1, IF: 8.063)
[15]Chaochao Tan#, Yunfeng Li#, Xiahe Huang, Meijin Wei, Ying Huang, Zhouqin Tang, He Huang, Wen Zhou, Yingchun Wang, Jiliang Hu*. Extensive protein S-nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis. Cell Death Dis, 2019, 10(12): 914. (SCI, JCR2, IF: 5.959)
[16]Yuyu Zhang, Chengbin Zhang, Qin Zhao, Wei Wei, Zhuo Dong, Lihong Shao, Jianbo Li, Wei Wu, Heng Zhang, He Huang, Feng Liu,* Shunzi Jin*. MiR-873/NDFIP1 axis promotes hepatocellular carcinoma growth and metastasis through AKT/mTOR-mediated Warburg effect. Am J Cancer Res, 2019, 9(5):927-944. ISSN：2156-6976 (SCI,JCR2, IF:3.998)
[17]Huiwen Song#, Xing Feng#, Heng Zhang#, Yunmei Luo, Juan Huang, Meihua Lin, Junfei Jin, Xue Ding, Shujing Wu, He Huang, Tian Yu, Mukun Zhang, Haiou Hong, Shihua Yao*, Yongxiang Zhao*, Zhiyong Zhang*. METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy, 2019, 15(8):1419-1437. (SCI, JCR1, IF: 11.059), 2019
[18]Xing Feng#, Yanyan Jia#, Yuyu Zhang#, Fei Ma#, Yuekun Zhu, Xuehui Hong, Qingxin Zhou, Ruixing He, Heng Zhang, Junfei Jin, Daxun Piao, He Huang*, Qinghua Li*, Xingfeng Qiu*, Zhiyong Zhang*. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth. Autophagy, 2019, 15(7):1130-1149. (*Corresponding Author, SCI, JCR1, IF: 11.059)
[19]Wei Zeng, Jinfeng Zhu, Junyuan Liu？, Yinglong Li？, Xiang Dong？, He Huang*, Li Shan*. miR-133b inhibits cell proliferation, migration and invasion of esophageal squamous cell carcinoma by targeting EGFR. Biomedicine & Pharmacotherapy, 2019, 111:476-484. (*Corresponding Author, SCI, JCR3, IF: 3.457)
[20]Jinfeng Zhu, Yi Liu, He Huang, Li Shan, Zhigang Han, Junyuan Liu, Yinglong Li, Xiang Dong, Wei Zeng*. MicroRNA-133b/EGFR axis regulates esophageal squamous cell carcinoma metastases by suppressing anoikis resistance and anchorage-independent growth. Cancer Cell Int, 2018, 18:193. (SCI, JCR3, IF: 3.960)

total55 1/3

firstpreviousnext last Page